Ask AI
ProCE Banner Activity

The Latest Data on CDH6-Targeted Treatment for Ovarian Cancer

Slideset

Download these slides with the latest data for CDH6-targeting antibody-drug conjugates in ovarian cancer and gain insight into promoting equitable access to clinical trials.

Released: January 26, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by educational grants from Daiichi Sankyo, Inc and Merck Sharp & Dohme, LLC

Daiichi Sankyo, Inc.

Merck Sharp & Dohme, LLC

Target Audience

This educational activity is intended for medical oncologists and other healthcare professionals who care for patients with ovarian cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Interpret the biologic rationale and mechanism of action for CDH6-targeting ADCs in ovarian cancer

  • Evaluate current and emerging clinical trial data on novel CDH6-targeted agents

  • Identify patients eligible for enrollment into clinical trials evaluating CDH6-targeting therapies